Antenatal Screening and Assessment

Antenatal screening and assessment is the structured process of monitoring maternal and fetal wellbeing and identifying women and pregnancies at higher risk across the course of pregnancy. It combines history-taking and physical assessment with laboratory tests, ultrasound, and screening for fetal aneuploidy and structural anomalies, so that increased risk can be recognised and care adjusted.

Definition

Antenatal screening and assessment is the application of clinical evaluation and screening tests during pregnancy to monitor maternal and fetal health and to identify pregnancies at increased risk of complications or fetal abnormality, distinguishing screening (risk estimation in an asymptomatic population) from diagnostic testing.

Scope

This topic outlines the purpose and main modalities of antenatal screening and assessment within nursing and midwifery care. It explains what is screened for and why, as a reference-educational overview, and does not specify which tests an individual should receive or how to interpret a particular result.

Core questions

• What maternal and fetal parameters are monitored across the antenatal period?
• How does screening differ from diagnostic testing in pregnancy?
• How are fetal aneuploidy and structural anomalies screened for?
• How is the result of a screening test interpreted in terms of risk rather than diagnosis?

Key concepts

• Screening versus diagnostic testing
• Risk assessment and risk stratification
• Combined first-trimester screening
• Cell-free DNA / non-invasive prenatal testing
• Mid-trimester anomaly ultrasound
• Maternal blood pressure and proteinuria monitoring
• Sensitivity, specificity, and false positives
• Informed choice and counselling

Mechanisms

Assessment is repeated across scheduled antenatal contacts: maternal observations (such as blood pressure and, where indicated, proteinuria), laboratory tests, and fetal monitoring (growth, ultrasound) build a longitudinal picture. Screening tests estimate the probability of a condition in an asymptomatic woman—for example combined first-trimester screening or cell-free DNA testing for fetal aneuploidy, and the mid-trimester ultrasound for structural anomalies—and a higher-risk screening result prompts the offer of diagnostic testing. The distinction between screening (risk estimation) and diagnosis is central, because screening tests have inherent false-positive and false-negative rates.

Clinical relevance

Screening and assessment allow earlier recognition of conditions such as anaemia, hypertensive disorders, gestational diabetes, and fetal anomaly, enabling timely adjustment of care. This entry describes the rationale and modalities at a conceptual level; it is educational and does not constitute a screening protocol or individualised testing advice.

Evidence & guidelines

Professional bodies publish guidance on antenatal screening, including standards for the routine mid-trimester ultrasound scan and recommendations on screening within antenatal care. Comparative studies have evaluated newer screening methods such as cell-free DNA testing against standard aneuploidy screening, generally reporting higher screening accuracy for the targeted trisomies while affirming that a positive screen requires diagnostic confirmation.

History

Antenatal assessment began with routine measurement of blood pressure and urine to detect pre-eclampsia and evolved through the introduction of obstetric ultrasound and biochemical serum screening. The advent of cell-free fetal DNA in maternal blood in the twenty-first century added a high-accuracy, non-invasive option for aneuploidy screening, reshaping the screening pathway.

Debates

How should screening be offered without becoming routinised testing?

Because screening estimates risk rather than providing a diagnosis and can lead to anxiety or further invasive testing, there is ongoing discussion about ensuring genuinely informed choice and counselling rather than presumptive uptake.

Seminal works

• bianchi-2014
• salomon-2011

Frequently asked questions

What is the difference between a screening test and a diagnostic test in pregnancy?

A screening test estimates the probability that a condition is present and applies to asymptomatic women, whereas a diagnostic test aims to confirm or exclude the condition; a higher-risk screen usually leads to the offer of a diagnostic test.

What is non-invasive prenatal testing?

It is a screening approach that analyses cell-free fetal DNA circulating in the mother's blood to estimate the risk of certain fetal chromosomal conditions, with high accuracy for the targeted trisomies, but a positive result still requires diagnostic confirmation.